Life sciences
Our specialist life sciences team understand the complex nature of the sector.
Time-to-market and funding are the crucial factors driving innovation and successful new pharmaceutical product launches, which in turn, require laboratories, vivaria, pilot plants and manufacturing facilities. Avison Young’s specialists understand the pharmaceutical product life cycle as well as the technical complexities that can create significant budgetary and scheduling risk.
We’ve successfully addressed the risks that surround real estate decision making throughout all phases of the product life cycle and across all technical aspects of planning, designing, engineering and constructing any type of life science space.

Life Sciences key contacts

News and updates
-
Avison Young strengthens North East presence with two strategic appointments in Leeds and Newcastle06 May 2025
-
Avison Young analysis shows investor confidence grows in industrial sector as big-box investment volumes rise 9% year-on-year30 April 2025
-
Avison Young celebrates Women of Influence, class of 202524 April 2025
-
UK office market remains resilient in first quarter17 April 2025